News

February 26 2024

Treatment of the First Patient with the A-FLUX Reducer System®

VahatiCor, Inc., today announced the treatment of the first patient with the A-FLUX Reducer System, a treatment for patients with angina or chest pain. “We have many interventional or surgical revascularization options for patients with advanced large coronary artery disease. However, a significant proportion still suffer from angina. The A-FLUX Reducer could help to fill that therapeutic void. It was an honor to perform the first-in-human implant and the patient is doing great,” said Dr. Jean-Michel Paradis.

CONTACT

General Inquiries

info@vahaticor.com

Complaints

complaints@vahaticor.com

Public Affairs

media@vahaticor.com

Headquarters

2903 Bunker Hill Lane, Suite 100, Santa Clara, CA 95054

Phone

(888) 627-0722

References

1. Refractory Angina research report. Delve Insight Business Research, July 2021.

© 2023 VahatiCor, Inc. Products are currently in development and are not available for sale. All rights strictly reserved.
MKT-00001 Rev. A